National Stroke Foundation


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved September 1999

Specific Treatments:

Asthma in pediatric patients

General Information

For the use of Accolate 10 mg oral Tablets for the prophylaxis and chronic treatment of asthma in pediatric patients 7 - 11 years of age.

Mechanism of Action